BioSpace News Archive

CONMED Corporation (NYSE: CNMD) today announced updated revenue expectations for the first quarter of 2020 to reflect the anticipated impact of the COVID-19 (Coronavirus) outbreak on its global business.

PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that the safety and efficacy outcomes from a multi-center study of Aquablation therapy replicated those achieved in its pivotal clinical trials.

Correvio Pharma Corp., and Hong Kong Teson Pharma Limited announced that Correvio International Sàrl, a wholly owned subsidiary of Correvio, and Teson have entered into an exclusive agreement for the commercialization of Aggrastat®.

The fear of the Coronavirus is currently spreading throughout Germany and the world.

CARAG AG announced the successful implantation of the first-ever transcatheter septal occluder with bioresorbable, metal-free framework, as part of a new international post-market registry.

Mesoblast Limited (Nasdaq: MESO; ASX:MSB) today announced that it plans to evaluate its allogeneic mesenchymal stem cell (MSC) product candidate remestemcel-L in patients with acute respiratory distress syndrome (ARDS) caused by coronavirus (COVID-19) in the United States, Australia, China and Europe.

Research Confirms Social Determinants of Health, Caregiving, and Quality of Care Among Top Drivers of Discrepancy in America

Prevencio, Inc. today announces a Microsoft Agreement which includes Microsoft’s Azure AI-computing Cloud and Microsoft’s marketing expertise, leading to Microsoft Healthcare’s 500+ salesforce selling Prevencio’s novel AI-driven HART cardiac blood tests.

Cocoon Medical (“Cocoon”), a leading global developer and provider of energy-based aesthetic systems for practitioners based in Barcelona, Spain, is pleased to announce the US introduction of its Primelase™ diode laser platform.

Excellere Partners, a Denver-based private equity firm focused on partnering with entrepreneurs and management teams, announced today that it has made a strategic investment in ParcelShield Holdings, LLC (“ParcelShield”), the leading provider of technology-enabled predictive parcel tracking and engagement services for healthcare clients.